Sanofi awaits FDA decision on license application

Pharmaceutical group Sanofi receives an extension of the FDA examination deadline for its license application.

Published 13sem1 source

≈ 19sSpeed

The fact

This extension reflects the complexity of validation procedures for new drugs in the United States.

The additional time allows Sanofi to complete required regulatory files.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on April 22, 2026